Venture Capital

Orca Bio: $250 Million Funding Raised For Orca-T Launch Readiness Ahead Of April PDUFA Date

By Amit Chowdhry ● Jan 11, 2026

Orca Bio announced it has raised $250 million in new equity financing and expanded access to debt capital as the late-stage biotech prepares for a potential U.S. commercialization of its lead cell therapy candidate, Orca-T, with an FDA action date set for April 6, 2026.

Diagonal Therapeutics: $125 Million Series B Raised To Advance DIAG723 Clustering Antibody Into the Clinic

By Amit Chowdhry ● Jan 10, 2026

Diagonal Therapeutics announced it has raised $125 million in an oversubscribed Series B financing to advance its lead program, DIAG723, a first-in-class “clustering antibody” designed to correct dysregulated receptor signaling implicated in hereditary hemorrhagic telangiectasia (HHT) and pulmonary arterial hypertension (PAH). The Watertown, Massachusetts-based biotech said the round was co-led by Sanofi Ventures and Janus Henderson Investors and will also support expansion of its broader clustering-antibody pipeline.

Unusual: $3.6 Million Raised To Help Brands Shape How AI Describes Them

By Amit Chowdhry ● Jan 10, 2026

Unusual, a startup that says it helps brands understand and influence how large language models describe their products and services, has raised $3.6 million in new funding as companies increasingly worry that AI chatbots can sway customer perception during the buying process.

Canopy: $22 Million Series B Raised To Expand Connected Safety And Location Intelligence Platform

By Amit Chowdhry ● Jan 10, 2026

Canopy, which provides connected safety platforms for U.S. health systems, has closed a $22 million Series B financing to accelerate growth of its location-based safety and operational tools. The round was led by 111° West Capital and ACME Capital, with participation from existing investors, as the company positions itself as a foundational alternative to what it describes as fragmented point solutions across hospital campuses.

Apella: $80 Million Raised To Bring Ambient AI And Computer Vision Into the Operating Room

By Amit Chowdhry ● Jan 10, 2026

Apella, a health technology company focused on operating room operations, announced it has raised $80 million in Series B financing, combining equity and venture debt, as it scales an ambient AI platform that uses computer vision to automate key surgical workflow data and feed it back into hospital systems. The round was led by HighlandX and included returning investors Vensana Capital, Casdin Capital, PFM Health Sciences, Upside Partnership, and Operator Partners. New investors in the financing included K2 HealthVentures, OpAmp Capital and Houston Methodist, which is also one of Apella’s health system customers. As part of the round, HighlandX partner Corey Mulloy joined Apella’s board.

Onsetto: $2.2 Million Seed Raised To Speed Product Development And Expand Go-To-Market

By Amit Chowdhry ● Jan 10, 2026

Onsetto, a Minneapolis-based fintech building a white-label platform to help banks and credit unions capture and retain primary business banking relationships, has raised $2.2 million in a Series Seed financing. The round was led by EJF Ventures, the early-stage fintech investing platform of EJF Capital. Additional participants included Idea Fund of La Crosse, The Perch Fund, and Minneapolis-based angel investors Daren Cotter and Bobby Astrup.

Blackbird.AI: $28 Million Raised As ARR Jumps 118% On Growing Demand To Counter Narrative Attacks

By Amit Chowdhry ● Jan 10, 2026

Blackbird.AI announced it has secured $28 million in new strategic funding as the company reported accelerating growth tied to rising demand from enterprises and national security organizations for tools to detect and counter narrative-based disinformation, misinformation, and deepfake-driven campaigns.

Corgi: $108 Million Raised And Regulatory Approval Won To Launch AI-Native Insurance Carrier For Startups

By Amit Chowdhry ● Jan 10, 2026

Corgi announced it has raised $108 million and recently secured regulatory approval to operate as a licensed, full-stack insurance carrier built specifically for startups, positioning the company to offer end-to-end coverage spanning underwriting, policy administration, and claims. Investors participating in the funding include Y Combinator, Kindred Ventures, Contrary, Oliver Jung, Glade Brook Capital Partners, Seven Stars, Leblon Capital (Andrej Henkler, Fadwa Ouardani), Fellows Fund, Alumni Ventures, Quadri Ventures, Vocal Ventures, Phosphor Capital and SV Angel, among others.

Tucuvi: $20 Million Series A Raised To Scale AI Care Management Platform

By Amit Chowdhry ● Jan 10, 2026

Tucuvi has raised $20 million in Series A funding to accelerate adoption of its AI Care Management platform across healthcare organizations, as systems grapple with workforce shortages, rising demand, and increasing operational complexity. The round was co-led by Cathay Innovation and Kfund through its early-growth fund Leadwind, with participation from existing investors Frontline Ventures, Seaya Ventures, and Shilling.

bit.bio Raises $50 Million Series C Led by M&G To Scale Human Cell Programming Platform

By Amit Chowdhry ● Jan 10, 2026

M&G Investments has led a $50 million Series C funding round for bit.bio, a Cambridge-based biotechnology company developing human cell programming technology to improve the speed and predictability of drug discovery and safety testing.

OpenAI And SoftBank Invest $1 Billion In SB Energy As Stargate Data Center Buildout Accelerates

By Amit Chowdhry ● Jan 10, 2026

SoftBank Group and OpenAI are investing a combined $1 billion in SB Energy to expand the company’s role as a development and execution partner for large-scale U.S. data center campuses and related energy infrastructure, the companies said Friday.

Kinaset Therapeutics: $103 Million Series B Closed To Advance Inhaled Pan-JAK Drug For Severe Asthma

By Amit Chowdhry ● Jan 10, 2026

Kinaset Therapeutics, a clinical-stage biopharmaceutical company focused on developing inhaled therapies for severe respiratory diseases, announced it has closed a $103 million oversubscribed Series B financing to fund mid-stage development of frevecitinib, its lead inhaled anti-inflammatory candidate for severe asthma and other serious respiratory diseases. The round was led by new investors RA Capital Management and Forge Life Science Partners, with participation from EQT Life Sciences, Vivo Capital, Schroders Capital, Willett Advisors, Pictet Alternative Advisors, and Sixty Degree Capital, alongside existing backers Atlas Venture, 5AM Ventures, and Gimv.

Rain: $250 Million Series C At $1.95 Billion Valuation Raised To Expand Stablecoin Payments Platform

By Amit Chowdhry ● Jan 10, 2026

Rain, which provides enterprise infrastructure for stablecoin-powered payments, has raised a $250 million Series C round led by ICONIQ, valuing the company at $1.95 billion. The financing brings Rain’s total funding to more than $338 million, and follows its Series B by about four months and its Series A by about 10 months.

Spruce Biosciences: Up To $50 Million Venture Debt Facility Secured To Support TA-ERT Path To Market

By Amit Chowdhry ● Jan 10, 2026

Spruce Biosciences announced it has entered into a venture debt loan facility for up to $50 million with Avenue Venture Opportunities Fund II, a fund of Avenue Capital Group, providing growth capital as the company advances tralesinidase alfa enzyme replacement therapy (TA-ERT) toward a planned biologics license application for Sanfilippo Syndrome Type B (MPS IIIB).

Veritas Capital To Buy Majority Stake In GHX

By Amit Chowdhry ● Jan 10, 2026

Veritas Capital announced it has entered into a definitive agreement, through an affiliate, to acquire a majority stake in Global Healthcare Exchange, a supply chain software platform that connects healthcare providers and suppliers. Existing shareholders Temasek and Warburg Pincus will remain invested alongside Veritas and support the company’s growth strategy. Financial terms were not disclosed.

Benefit Street Partners Closes Real Estate Opportunistic Debt Fund II At $10 Billion

By Amit Chowdhry ● Jan 10, 2026

Benefit Street Partners (BSP), a credit-focused alternative asset manager, announced it has reached a final close for BSP Real Estate Opportunistic Debt Fund II (ODF II), providing $10 billion of investable capital inclusive of related vehicles and anticipated leverage, backed by $3 billion of equity commitments. BSP said the raise is the largest in its history for its U.S. real estate debt strategy.

Presto Adds $10 Million To Advance Voice AI Rollout for Enterprise QSR Drive-Thrus

By Amit Chowdhry ● Jan 10, 2026

Presto announced it has added $10 million in new funding to accelerate its AI roadmap and expand deployments of its enterprise voice assistant for quick-service restaurant drive-thrus. The company positioned the raise as growth capital to scale production implementations and deepen its lead in voice AI for large QSR brands.

PureSpectrum Partners With TA Associates To Fund Product Innovation

By Amit Chowdhry ● Jan 10, 2026

PureSpectrum, a market research technology company, said it has entered into a strategic partnership with TA Associates to support continued innovation, platform scaling, and expanded value for customers across the market research ecosystem. Financial terms were not disclosed.

Carna Health: $8 Million Raised To Expand Global Chronic Kidney Disease Screening Platform

By Amit Chowdhry ● Jan 10, 2026

Carna Health announced it has raised $8 million to expand global access to its chronic kidney disease screening and care management technology, following a strategic partnership with Siemens Healthineers to scale preventive kidney care worldwide.

UPenn, BioNTech, And Osage University Partners Launch $50 Million Seed Fund To Back Penn Life Science Startups

By Amit Chowdhry ● Jan 10, 2026

The University of Pennsylvania, BioNTech SE, and Osage University Partners (OUP) announced the launch of the $50 million Penn-BioNTech Innovative Therapeutics Seed Fund (PxB Fund), a dedicated venture fund focused on early-stage life science companies originating from Penn.

Hadrian Raises Funding At $1.6 Billion Valuation To Scale New U.S. Factories

By Amit Chowdhry ● Jan 10, 2026

Hadrian, a company focused on building advanced U.S. manufacturing capacity for aerospace, defense, and critical infrastructure, announced it has raised expanded capital led by accounts advised by T. Rowe Price Associates. The financing values the company at $1.6 billion, Hadrian said.

Guidepost Growth Equity Closes $521 Million Oversubscribed Fund IV

By Amit Chowdhry ● Jan 10, 2026

Guidepost Growth Equity announced it has closed its fourth fund, Guidepost Growth Equity IV, L.P., with $521 million in total commitments, exceeding the firm’s $500 million fundraising target. The growth equity firm said the vehicle was oversubscribed and drew commitments from both new and existing limited partners.

Vizgen: $48 Million Funding Raised To Scale Spatial Multi-Omics Platform

By Amit Chowdhry ● Jan 10, 2026

Vizgen, a spatial multi-omics company, announced it has closed a $48 million financing led by ARCH Venture Partners and co-led by M Ventures and Northpond Ventures, with participation from existing investors.

Enhanced Digital Group: Series A Funding Raised For Expanding Institutional Crypto Derivatives Offering

By Amit Chowdhry ● Jan 10, 2026

Enhanced Digital Group (EDG), a provider of digital asset derivatives solutions, said StoneX Digital, a division of StoneX Group Inc. (Nasdaq: SNEX), led its Series A financing round.

Abbelight: Series B Raised To Expand Super-Resolution Microscopy Adoption

By Amit Chowdhry ● Jan 10, 2026

Abbelight announced it has closed a Series B financing round led by AVANT BIO, as the Paris-based company looks to accelerate product innovation and broaden commercial adoption of its super-resolution microscopy solutions across a wider customer base.

EpiBiologics: $107 Million Series B Raised To Advance Tissue-Selective EGFR Degrader And Bispecific Antibody Pipeline

By Amit Chowdhry ● Jan 10, 2026

EpiBiologics announced it has closed a $107 million Series B financing to advance a pipeline of bispecific antibodies designed to selectively degrade extracellular protein targets in oncology and immunology. The round was co-led by GV and Johnson & Johnson, through Johnson & Johnson Innovation – JJDC, with participation from new and existing investors.

32 Biosciences: $40M Series A Launched To Advance GI Mucosal-Immune Therapeutics

By Amit Chowdhry ● Jan 10, 2026

32 Biosciences, a gastrointestinal-focused biotechnology company, announced it will launch a $40 million Series A financing during the 2026 J.P. Morgan Healthcare Conference in San Francisco, scheduled for January 12–15, 2026.

BrightHeart: €11 Million Series A Raised To Expand Prenatal Ultrasound AI Platform

By Amit Chowdhry ● Jan 10, 2026

BrightHeart, a Paris-based developer of AI software for prenatal ultrasound, said it has closed an €11 million Series A financing to fund U.S. commercialization, broader European expansion and continued product development for its B-Right AI Platform.

Spangle AI: $15 Million Series A Closed To Build Agentic Infrastructure For Commerce

By Amit Chowdhry ● Jan 10, 2026

Spangle AI, an agentic infrastructure layer for commerce, said it raised a $15 million Series A round led by NewRoad Capital Partners with participation from Madrona, DNX Ventures, Streamlined Ventures, and strategic angel investors, bringing total funding to $21 million.

Luxury Presence: $37 Million Raised To Advance Presence CRM, An AI Relationship Engine For Real Estate Agents

By Amit Chowdhry ● Jan 10, 2026

Luxury Presence, a growth platform used by more than 87,000 residential real estate agents and brands, announced it raised $37 million in new capital to accelerate the development and launch of Presence CRM, which it is positioning as an AI-driven system designed to surface deal opportunities from an agent’s existing network.